Kezia Lizardo
Kezia Lizardo publishes mostly in Epidemiology, Cardiology and Cardiovascular Medicine and Infectious Diseases, on topics such as Trypanosoma species research and implications, Cardiomyopathy and Myosin Studies and Cardiovascular Function and Risk Factors.
- World rank
- #4,342,751 of 7,710,434 ranked researchers
- Rank in United States
- #1,164,583 of 1,627,098
- Works
- 21
- Citations
- 240
- Citations per work
- 11.4
What does Kezia Lizardo research?
Kezia Lizardo's work is mostly in Medicine (67%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1466.7%
- Medicine1466.7%
- Everything else521.6%
- Life Sciences211.7%
- 1Epidemiology30% of their works
- 2Cardiology and Cardiovascular Medicine23% of their works
- 3Infectious Diseases7% of their works
- 4Oncology7% of their works
- 5Immunology7% of their works
- 6Cell Biology5% of their works
Research topics
- Trypanosoma species research and implications
- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Tuberculosis Research and Epidemiology
- Metabolism, Diabetes, and Cancer
- Cardiovascular Effects of Exercise
- Mycobacterium research and diagnosis
- Adipokines, Inflammation, and Metabolic Diseases
Which keywords describe Kezia Lizardo's research?
The keywords of their largest research topics: Epidemiology, Drug Resistance, Chagas Disease, Trypanosoma cruzi, Genetic Mutations, Cardiomyopathies, Myosin and Diagnosis.
- Sudden Death
- Mycobacterium avium
- Inflammation
- Adipose Tissue
- Tuberculosis
- Echocardiography
- Treatment
- Diagnosis
- Cardiomyopathies
- Trypanosoma cruzi
- Drug Resistance
- Epidemiology
- Chagas Disease
- Genetic Mutations
- Myosin
- Obesity
- Chamber Quantification
- Mycobacterium tuberculosis
- AMP-Activated Protein Kinase
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Metformin
- Nontuberculous Mycobacteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Epidemiology173 topics
- Drug Resistance152 topics
- Chagas Disease121 topic
- Trypanosoma cruzi121 topic
- Genetic Mutations92 topics
- Cardiomyopathies71 topic
- Myosin71 topic
- Diagnosis52 topics
- Obesity52 topics
- Treatment52 topics
- Chamber Quantification31 topic
- Echocardiography31 topic
- Mycobacterium tuberculosis31 topic
- Tuberculosis31 topic
- AMP-Activated Protein Kinase21 topic
- Adipose Tissue21 topic
- Arrhythmogenic Right Ventricular Cardiomyopathy21 topic
- Inflammation21 topic
- Metformin21 topic
- Mycobacterium avium21 topic
- Nontuberculous Mycobacteria21 topic
- Sudden Death21 topic
Where does Kezia Lizardo work?
Kezia Lizardo's main affiliation in the publication record is Center for Discovery, United States.
How many publications and citations does Kezia Lizardo have?
OpenAlex counts 21 works and 240 citations for Kezia Lizardo, an h-index of 9, ranking #4,342,751 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kezia Lizardo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.